| Turkey | Austria | Spain | |
| EGFR, ALK, ROS1, PG-L1 | from $450 | - | - |
Medically reviewed by
Fahad MawloodNo hidden fees – just official clinic prices. Pay at the clinic for EGFR, ALK, ROS1, PG-L1 upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in EGFR, ALK, ROS1, PG-L1 and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your EGFR, ALK, ROS1, PG-L1 journey.
Dr. Mustafa Solak is a medical oncologist with expertise in breast, testicular, ovarian, lung, head-neck, and gastrointestinal cancers. He graduated from Hacettepe University School of Medicine. He completed his residency at Istanbul Sisli Etfal Teaching and Research Hospital. He then pursued a fellowship at Hacettepe University Cancer Institute.
Dr. Solak has managed many complex cancer cases. He has contributed to clinical advancements at respected centers, including the University of Texas MD Anderson Cancer Center. He has also worked at Hitit University Corum Training Hospital and Medical Park Hospital. His experience shows a strong commitment to cancer care and research.
Dr. Ofer Merimsly is the best sarcoma, lymphoma, and lung cancer doctor within Israel and in the world. Also specializes in Whipple surgery treatment for patients with pancreatic cancer. Head of the National Center for sarcomas of bone and soft tissues of the Tel Aviv Medical Center Sourasky (Ichilov).
Specialty:
Education and specialization:
Membership:
Dr. Elnur Sahibov is a licensed Radiation Oncologist with 8 years of medical training and clinical experience. He completed his undergraduate and specialization studies at Marmara University Faculty of Medicine. From 2012 to 2016, he focused on advanced radiation oncology techniques.
Dr. Sahibov is known for his expertise in cancer treatment. He has helped improve patient outcomes and uses evidence-based protocols. He is accredited by leading medical institutions and is dedicated to ongoing professional development in oncology.